Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Winter

Showing results (1191-1200 of 1,268) with videos related to

Pageof 127
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|July 24, 2007
Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarctionRobert W Grauss, Elizabeth M Winter, John van Tuyn, et al.
Journal of Surgical Oncology|June 20, 2017
Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinomaJeffrey D Epstein, Geoffrey Kozak, Zhi Ven Fong, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Annals of Surgery|July 3, 2015
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisJordan M Winter, Wei Jiang, Olca Basturk, et al.
Nature|July 8, 2011
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
ESC Heart Failure|December 26, 2023
Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trialJelle P Man, Marcel G W Dijkgraaf, M Louis Handoko, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Pageof 127

Showing results (1191-1200 of 1,268) with videos related to

Sort By:
Pageof 127
American Journal of Physiology. Heart and Circulatory Physiology|July 24, 2007
Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarctionRobert W Grauss, Elizabeth M Winter, John van Tuyn, et al.
Journal of Surgical Oncology|June 20, 2017
Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinomaJeffrey D Epstein, Geoffrey Kozak, Zhi Ven Fong, et al.
Molecular Cancer|May 28, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Research Square|May 4, 2026
AcTor, a novel mTOR stimulator, potentiates ixazomib for the treatment of acute myeloid leukemiaShakti P Pattanayak, Odai Darawshi, Omid Hajihassani, et al.
Annals of Surgery|July 3, 2015
Recurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisJordan M Winter, Wei Jiang, Olca Basturk, et al.
Nature|July 8, 2011
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesisGina M DeNicola, Florian A Karreth, Timothy J Humpton, et al.
Oncogene|September 22, 2015
The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cellsF F Blanco, M Jimbo, J Wulfkuhle, et al.
Cancer Research|July 9, 2017
Posttranscriptional Regulation of <i>PARG</i> mRNA by HuR Facilitates DNA Repair and Resistance to PARP InhibitorsSaswati N Chand, Mahsa Zarei, Matthew J Schiewer, et al.
ESC Heart Failure|December 26, 2023
Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trialJelle P Man, Marcel G W Dijkgraaf, M Louis Handoko, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Pageof 127